study_id,author_year,outcome,effect,standard_error,ci_low,ci_high,n_treat,n_control,notes
S1,Smith 2018,Primary,0.12,0.08,-0.04,0.28,55,58,Small RCT; mild benefit
S2,Nguyen 2019,Primary,0.05,0.06,-0.07,0.17,120,118,Multi-site RCT
S3,Garcia 2020,Primary,0.20,0.10,0.00,0.40,42,40,Higher baseline risk
S4,Patel 2021,Primary,-0.02,0.07,-0.16,0.12,80,84,No clear effect
S5,Kim 2022,Primary,0.15,0.09,-0.03,0.33,65,63,Adherence-adjusted analysis
S6,Osei 2023,Primary,0.08,0.05,-0.02,0.18,150,152,Pragmatic trial
